Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells

被引:1
|
作者
Abdelsalam, Mohamed [1 ,2 ]
Zmyslia, Mariia [3 ]
Schmidtkunz, Karin [4 ]
Vecchio, Anita [1 ]
Hilscher, Sebastian [5 ]
Ibrahim, Hany S. [1 ,6 ]
Schutkowski, Mike [5 ]
Jung, Manfred [4 ,7 ]
Jessen-Trefzer, Claudia [3 ,8 ]
Sippl, Wolfgang [1 ,9 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Dept Med Chem, Halle, Germany
[2] Alexandria Univ, Fac Pharm, Dept Pharmaceut Chem, Alexandria, Egypt
[3] Univ Freiburg, Inst Organ Chem, Freiburg, Germany
[4] Univ Freiburg, Inst Pharmaceut Sci, Freiburg, Germany
[5] Martin Luther Univ Halle Wittenberg, Inst Biochem, Dept Enzymol, Halle, Germany
[6] Egyptian Russian Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo, Egypt
[7] Univ Freiburg, CIBSS Ctr Integrat Biol Signalling Studies, Freiburg, Germany
[8] Univ Freiburg, Inst Organ Chem, D-79104 Freiburg, Germany
[9] Martin Luther Univ Halle Wittenberg, Inst Pharm, Dept Med Chem, D-06120 Halle, Germany
关键词
epigenetics; HDACs; hypoxia; nitroreductases; prodrugs; NITROREDUCTASE; HYPOXIA; ENZYME; GDEPT;
D O I
10.1002/ardp.202300536
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Although histone deacetylase (HDAC) inhibitors show promise in treating various types of hematologic malignancies, they have some limitations, including poor pharmacokinetics and off-target side effects. Prodrug design has shown promise as an approach to improve pharmacokinetic properties and to improve target tissue specificity. In this work, several bioreductive prodrugs for class I HDACs were designed based on known selective HDAC inhibitors. The zinc-binding group of the HDAC inhibitors was masked with various nitroarylmethyl residues to make them substrates of nitroreductase (NTR). The developed prodrugs showed weak HDAC inhibitory activity compared to their parent inhibitors. The prodrugs were tested against wild-type and NTR-transfected THP1 cells. Cellular assays showed that both 2-nitroimidazole-based prodrugs 5 and 6 were best activated by the NTR and exhibited potent activity against NTR-THP1 cells. Compound 6 showed the highest cellular activity (GI50 = 77 nM) and exhibited moderate selectivity. Moreover, activation of prodrug 6 by NTR was confirmed by liquid chromatography-mass spectrometry analysis, which showed the release of the parent inhibitor after incubation with Escherichia coli NTR. Thus, compound 6 can be considered a novel prodrug selective for class I HDACs, which could be used as a good starting point for increasing selectivity and for further optimization. A new series of prodrugs for class I histone deacetylases (HDACs) was designed and synthesized by masking the zinc-binding group of reported HDAC1-3 inhibitors with different nitroaromatic moieties. Among these prodrugs, compound 6 showed the most potent inhibitory activity against nitroreductase (NTR)-transfected leukemic cells. Liquid chromatography-mass spectrometry analysis confirmed the activation of compound 6 and showed the release of its parent inhibitor after incubation with NTR.image
引用
下载
收藏
页数:14
相关论文
共 50 条
  • [21] Design, synthesis, and biological evaluation of selective FLT3 inhibitors for the treatment of acute myeloid leukemia
    Kim, Hyuntae
    Yang, Jee Sun
    Lee, Chulho
    Oh, Changmok
    Han, Gyoonhee
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [22] Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors
    Zhang, Xuan
    Kong, Yannan
    Zhang, Jie
    Su, Mingbo
    Zhou, Yubo
    Zang, Yi
    Li, Jia
    Chen, Yi
    Fang, Yanfen
    Zhang, Xiongwen
    Lu, Wei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 95 : 127 - 135
  • [23] Design, Synthesis, and Biological Evaluation of Histone Deacetylase Inhibitors Derived from Erianin and Its Derivatives
    Yang, Yawen
    Liu, Qingqing
    Wang, Xinyi
    Gou, Shaohua
    CHEMMEDCHEM, 2023, 18 (13)
  • [24] Design, synthesis, and biological evaluation of novel histone deacetylase 1 inhibitors through click chemistry
    Sun, Qiao
    Yao, Yiwu
    Liu, Chunping
    Li, Hua
    Yao, Hequan
    Xue, Xiaowen
    Liu, Jinsong
    Tu, Zhengchao
    Jiang, Sheng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (11) : 3295 - 3299
  • [25] Design, synthesis and biological evaluation of isoquinoline-based derivatives as novel histone deacetylase inhibitors
    Yang, Wei
    Li, Lixuan
    Wang, Yulan
    Wu, Xiaowei
    Li, Tingting
    Yang, Nan
    Su, Mingbo
    Sheng, Li
    Zheng, Mingyue
    Zang, Yi
    Li, Jia
    Liu, Hong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (17) : 5881 - 5890
  • [26] Design, Synthesis, and Biological Evaluation of Tetrahydroisoquinoline-Based Histone Deacetylase 8 Selective Inhibitors
    Taha, Taha Y.
    Aboukhatwa, Shaimaa M.
    Knopp, Rachel C.
    Ikegaki, Naohiko
    Abdelkarim, Hazem
    Neerasa, Jayaprakash
    Lu, Yunlong
    Neelarapu, Raghupathi
    Hanigan, Thomas W.
    Thatcher, Gregory R. J.
    Petukhov, Pavel A.
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (08): : 824 - 829
  • [27] Design, synthesis, and biological evaluation of novel histone deacetylase inhibitors as anti-cancer agents
    Al-Hamashi, Ayad
    Tillekeratne, L. M. Viranga
    Dlamini, Samikeliso
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [28] Histone deacetylase inhibitors up-regulate costimulatory/adhesion molecules in acute myeloid leukemia cells.
    Maeda, T
    Towatari, M
    Kosugi, H
    Saito, H
    BLOOD, 2000, 96 (11) : 119A - 119A
  • [29] Synthesis and biological evaluation of cyclic tetrapeptides serving as histone deacetylase inhibitors
    Singh, Erinprit K.
    Lapera, Stephanie
    Nazarova, Lidia
    Vasko, Robert C.
    McAlpine, Shelli R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [30] Computer-aided molecular design of Histone Deacetylase Class I inhibitors
    Esposito, Emilio Xavier
    Cook, Gregory R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231